U.S. markets open in 1 hour 15 minutes
  • S&P Futures

    3,693.00
    -39.00 (-1.05%)
     
  • Dow Futures

    29,508.00
    -242.00 (-0.81%)
     
  • Nasdaq Futures

    11,400.50
    -155.25 (-1.34%)
     
  • Russell 2000 Futures

    1,700.40
    -20.40 (-1.19%)
     
  • Crude Oil

    82.12
    -0.03 (-0.04%)
     
  • Gold

    1,658.60
    -11.40 (-0.68%)
     
  • Silver

    18.67
    -0.21 (-1.14%)
     
  • EUR/USD

    0.9704
    -0.0035 (-0.36%)
     
  • 10-Yr Bond

    3.7050
    0.0000 (0.00%)
     
  • Vix

    31.54
    -1.06 (-3.25%)
     
  • GBP/USD

    1.0844
    -0.0042 (-0.39%)
     
  • USD/JPY

    144.7340
    +0.6120 (+0.42%)
     
  • BTC-USD

    19,383.26
    +413.42 (+2.18%)
     
  • CMC Crypto 200

    443.43
    +14.65 (+3.42%)
     
  • FTSE 100

    6,931.19
    -74.20 (-1.06%)
     
  • Nikkei 225

    26,422.05
    +248.07 (+0.95%)
     

Oncology Nutrition Global Market Report 2022

·4 min read
ReportLinker
ReportLinker

Major players in the oncology nutrition market are B. Braun Melsungen AG, Danone India, Abbott Laboratories, Nestle S. A. , Victus, Hormel Food Corporation, Meiji Holdings, Pfizer Inc. , Baxter International, Mead Johnson Nutrition Company, Fresenius Kabi AG, Braun Melsungen AG, Auris Health Inc.

New York, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Oncology Nutrition Global Market Report 2022" - https://www.reportlinker.com/p06317656/?utm_source=GNW
, Aceto, and Hansen Medical.

The global oncology nutrition market is expected to grow from $1.34 billion in 2021 to $1.51 billion in 2022 at a compound annual growth rate (CAGR) of 12.6%. The oncology nutrition market is expected to grow to $2.13 billion in 2026 at a CAGR of 8.9%.

The oncology nutrition market consists of sales of oncology nutrition products by entities (organizations, sole traders, and partnerships) that are used to improve clinical outcomes in certain cancer types.Oncology nutrition refers to eating a healthy and balanced diet prescribed for a cancer patient.

Eating the right kinds of food before, during, and after treatment can help patients feel better and stay stronger.

The main types of cancer in oncology nutrition are blood cancer, breast cancer, stomach and gastrointestinal cancers, liver cancer, pancreatic cancer, and others.Stomach and gastrointestinal cancers refer to cancers that are caused in any part of the stomach.

The different types of nutrition include enteral nutrition and parenteral nutrition and are employed in hospitals, homecare, specialty clinics, and other end users.

North America was the largest region in the oncology nutrition market in 2021.Asia-Pacific is expected to be the fastest-growing region in the forecast period.

The regions covered in the oncology nutrition market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The oncology nutrition market research report is one of a series of new reports that provides oncology nutrition market statistics, including oncology nutrition industry global market size, regional shares, competitors with an oncology nutrition market share, detailed oncology nutrition market segments, market trends and opportunities, and any further data you may need to thrive in the oncology nutrition industry. This oncology nutrition market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

An increase in the prevalence of cancer is significantly contributing to the growth of the oncology nutrition market going forward.Cancer incidence refers to the number of new cancer cases arising in a specified population over a given period of time.

People suffering from cancer require adequate food with sufficient nutrition.As a result, the rise in the incidence of cancer increases the demand for oncology nutrition.

For instance, in 2020, according to the World Health Organization, a Switzerland-based health agency, 19.3 million new cancer cases were registered, and almost 10.0 million cancer deaths occurred in the US. Therefore, the rising incidence of cancer will contribute to the growth of the oncology nutrition market.

Strategic partnerships have emerged as a key trend gaining popularity in the oncology nutrition market.Organizations operating in oncology nutrition are focused on strategic partnerships to meet consumer demand and reinforce their position.

For instance, in October 2021, NIHR Cancer and Nutrition, a UK-based cancer organization, collaborated with World Cancer Research Fund, a UK-based non-profit association.This partnership focuses on training and delivering consistent information on nutrition to cancer patients.

Furthermore, in March 2022, Hope Connections, a US-based non-profit organization, collaborated with Food & Friends, a US-based oncology nutrition organization, to help with nutrition awareness in oncology.

In August 2019, Boston Scientific Corporation, a US-based manufacturer of medical devices, acquired BTG plc for an undisclosed amount.The acquisition is expected to enable Boston Scientific Corporation to offer best-in-class technologies, unparalleled clinical evidence, and a strengthened commercial infrastructure to support physicians treating some of the most challenging diseases impacting patient health around the world.

BTG Limited is a UK-based company that develops products used in minimally invasive procedures targeting cancer and vascular diseases, as well as specialty pharmaceuticals for the same.

The countries covered in the oncology nutrition market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Read the full report: https://www.reportlinker.com/p06317656/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001